← All projects
Immune renewal

LIfT BioSciences neutrophil therapy

LIfT BioSciences

This could help an older immune system respond better to infections, vaccines and damaged cells.

WHAT IT IS TRYING TO CHANGE

What the project is doing

LIfT BioSciences neutrophil therapy is being developed as part of the wider effort to prevent, delay or repair age-related decline.

What this could do for you

This could help an older immune system respond better to infections, vaccines and damaged cells.

What has to happen next

The next checkpoint is whether the treatment is safe enough and shows enough biological activity to continue.

What could stop it

The study is mainly about safety and dose. It may not show whether people actually live longer or feel better.

WHERE IT STANDS

Current evidence and outlook

LIfT BioSciences neutrophil therapy is being developed as part of the wider effort to prevent, delay or repair age-related decline.

Likely path

Often 5–10 years from broad availability, if safety and later studies succeed.

Why this estimate

Early human testing answers only part of what is needed.

Record checked: 2026-08-27

ORIGINAL EVIDENCE

Research details and sources

The sources below support the project record. RejuvAccess separately checks whether a practical route is open and worth pursuing.

  1. LIfT BioSciences — January 2026 clinical-development update
  2. LIfT BioSciences — current programme
MAKE IT PERSONAL

Could this matter for your situation?

Ask RejuvAccess to check the evidence, access route, cost and next step for you.

Start an access check